Back
InMed Pharmaceuticals Vs. Aurinia Pharmaceuticals Industry Stock Comparison
Sell
30
INM
InMed Pharmaceuticals
Last Price:
0.24
Seasonality Move:
23.96%
Sell
46
AUPH
Aurinia Pharmaceuticals
Last Price:
7.21
Seasonality Move:
24.32%
Sell
30
InMed Pharmaceuticals (INM)
is a Sell
Is InMed Pharmaceuticals a Buy, Sell or Hold?
- The current InMed Pharmaceuticals [INM] share price is $0.24. The Score for INM is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- INM is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Aurinia Pharmaceuticals (AUPH)
is a Sell
Is Aurinia Pharmaceuticals a Buy, Sell or Hold?
- The current Aurinia Pharmaceuticals [AUPH] share price is $7.21. The Score for AUPH is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- AUPH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
INM Stock Price Chart
What is InMed Pharmaceuticals's stock price today?
-
The InMed Pharmaceuticals share price today is $0.24
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INM is experiencing selling pressure, which indicates risk of future bearish movement.
AUPH Stock Price Chart
What is Aurinia Pharmaceuticals's stock price today?
-
The Aurinia Pharmaceuticals share price today is $7.21
The current trend is moderately bullish and AUPH is experiencing slight buying pressure.
INM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 45.36 | Sell |
| Chaikin Money Flow: | -183468 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.21 - 0.29) | Sell |
| Bollinger Bands (100): | (0.19 - 0.31) | Sell |
AUPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.09 | Buy |
| Relative Strength Index (14 RSI): | 53.16 | Buy |
| Chaikin Money Flow: | 525662 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.95 - 7.29) | Buy |
| Bollinger Bands (100): | (5.6 - 7.08) | Buy |
INM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.29 | Sell |
| 20-day SMA: | 0.26 | Sell |
| 50-day SMA: | 0.27 | Sell |
| 200-day SMA: | 0.29 | Sell |
| 8-day EMA: | 0.27 | Sell |
| 20-day EMA: | 0.27 | Sell |
| 50-day EMA: | 0.26 | Sell |
| 200-day EMA: | 0.45 | Sell |
AUPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.24 | Sell |
| 20-day SMA: | 7.11 | Buy |
| 50-day SMA: | 7.03 | Buy |
| 200-day SMA: | 6.07 | Buy |
| 8-day EMA: | 7.24 | Sell |
| 20-day EMA: | 7.16 | Buy |
| 50-day EMA: | 6.91 | Buy |
| 200-day EMA: | 6.64 | Buy |
InMed Pharmaceuticals Earnings Growth & INM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Aurinia Pharmaceuticals Earnings Growth & AUPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.57 per share, and an increase next year of $0.36 per share.
InMed Pharmaceuticals Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Aurinia Pharmaceuticals Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||